2023-05-23-PitchBook-2023年一季度医疗保健服务报告（英）_31页_4mb

报告摘要

Deal Volume Decline: PE investment activity in healthcare services saw a -21.5% YoY decrease in Q1 2023 (200 deals), ending a five-quarter decline while still surpassing pre-2018 averages.
Leverage & Valuation Adjustments: With shifting interest rates and reduced bank loans (now ~4-5x vs. 6x), hospitals/residential facilities face capital pressures. Multiples for growth deals lagged 2021 levels, except in mental health.
Process & Risk Mitigation: Deal processes are slower and more cautious. Seller earnouts reemerged to bridge valuation gaps, reflecting post-2021 competitiveness.

Focus: Sponsors prioritize cash-pay segments (e.g., medspa, private duty home, dentistry) and durable-growth business lines, especially in workforce-shortage areas.
Strategies: Minority equity injects for growth acceleration (e.g., Team Health) and platform buyouts via “wait-and-see” sponsor-to-sponsor deals (United Digestive & Novocardia). Cash-pay services appear resilient amid recession fears.

Medicare Advantage (MA): RADV rules tighten HCC coding scrutiny, squeezing MA plan margins via increased recoupments; blended risk-adjustment models rollout (33% new methodology) may pressure revenue.
High-Yield Debt: Morningstar data shows ~22% of healthcare services bonds are distressed (25% in healthcare overall), signaling capex strains, especially with ongoing wage inflation.

Market Map: PE ecosystem concentrated in leadership-focused specialties (cardiology, oncology) and cash-heavy services (skill care, behavioral health).
Sector-Specific Deal Trends:
- Generalist Providers: Primary care and emergency services record steady activity.
- Multispecialty: High-volume specialties like cardiology (up 5% YoY) lead deal activity, though valuations remain premium (~$200M-+$1B).
- Mental Health: Services platform scarcity pushes valuations upward, despite inflation/multiples pressure.

Recent Acquisitions: Heart and Vascular Partners acquired United Cardiology Partners; TPG-backed OneOncology sale to AmerisourceBergen signals larger deals possible via consolidation.
Exit Drivers: Shrinking buyout opportunities and growing financial pressures delayed exits. Single-digit multiples recorded in distressed assets (e.g., ProMedica’s assets) weighed heavily on IRR targets.

Valuation Realignment: Across services, PE-backed deals reflect a new normal—lower multiples, higher scrutiny on margins, and earlier work on VBC platforms.
Geographical & Sector Neutrality: Key risks include regulatory shifts (MA recoupments) and workforce trends, but cash-pay services could provide exits if recession hits aggressive growth sectors.

展开完整摘要